IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Myelodysplastic/Myeloproliferative Neoplasms
Prelude Therapeuticsmonoclonal_antibodyPhase 2Active
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
45 Active assets in the Myelodysplastic/Myeloproliferative Neoplasms cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE M.D. Anderson Cancer Center | Phase 3 | BBB |
Cytosin-Arabinosid Fred Hutchinson Cancer Center | Phase 3 | BBB |
CYCLOSPORIN A Memorial Sloan Kettering Cancer Center | Phase 3 | BBB |
Evomela M.D. Anderson Cancer Center | Phase 2/3 | BBB |
Busulphan Jacqueline Garcia, MD | Phase 2/3 | BBB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →